Filing detail

8-KTicker UNCYCIK 0001766140

Unicycive Therapeutics, Inc. 8-K

Accession 0001213900-25-111045

Filed Nov 13, 7:00 PM ETAccepted Nov 14, 5:10 PM ETSize 257.8 KB

Filed (ET)

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:10 PM ET

File size

257.8 KB

SEC accession

0001213900-25-111045

Filing details

CIK
0001766140
Incorporated
DE
Entity type
operating

Related parties

  • filerCIK 0001766140

Documents

Attached files
14 items
  • ea0265675-8k_unicycive.htm

    8-K

    CURRENT REPORT

  • ea026567502ex1-1_unicycive.htm

    EX-1.1

    AMENDMENT NO. 1 TO SALES AGREEMENT, DATED NOVEMBER 14, 2025, BETWEEN UNICYCIVE THERAPEUTICS, INC. AND GUGGENHEIM SECURITIES, LLC

  • ea026567502ex5-1_unicycive.htm

    EX-5.1

    OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP

  • ex5-1_001.jpg

    GRAPHIC

    GRAPHIC

  • uncy-20251114.xsd

    EX-101.SCH

    XBRL SCHEMA FILE

  • uncy-20251114_lab.xml

    EX-101.LAB

    XBRL LABEL FILE

  • uncy-20251114_pre.xml

    EX-101.PRE

    XBRL PRESENTATION FILE

  • R1.htm

    XML

    IDEA: XBRL DOCUMENT

  • Show.js

    XML

    IDEA: XBRL DOCUMENT

  • report.css

    XML

    IDEA: XBRL DOCUMENT

  • FilingSummary.xml

    XML

    IDEA: XBRL DOCUMENT

  • MetaLinks.json

    JSON

    IDEA: XBRL DOCUMENT

  • 0001213900-25-111045-xbrl.zip

    ZIP

    IDEA: XBRL DOCUMENT

  • ea0265675-8k_unicycive_htm.xml

    XML

    IDEA: XBRL DOCUMENT